Search results (159)
« Back to PublicationsPeriductal iron-corrected T1 is a predictor of adverse outcomes in large-duct primary sclerosing cholangitis.
Conference paper
Selvaraj EA. et al, (2026), BMC Med Imaging
Variations in Estimated Glomerular Filtration Rate Across Countries in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease and Their Association With Liver Fibrosis: A Multicenter Study.
Journal article
Zhao J. et al, (2025), MedComm (2020), 6
Imaging Biomarkers in Metabolic Dysfunction Associated Steatotic Liver Disease
Journal article
Gul D. and Pavlides M., (2025), Current Hepatology Reports, 24
Investigation of the Effect of Isotonic Drinks on Quantitative MRI Markers of the Liver and Spleen.
Journal article
Pittas NN. et al, (2025), NMR Biomed, 38
Severe Dietary Energy Restriction for Compensated Cirrhosis Due to Metabolic Dysfunction-Associated Steatotic Liver Disease: A Randomised Controlled Trial.
Journal article
Koutoukidis DA. et al, (2025), J Cachexia Sarcopenia Muscle, 16
acFibroMASH Index for the Diagnosis of Fibrotic MASH and Prediction of Liver-related Events: An International Multicenter Study.
Journal article
Feng G. et al, (2025), Clin Gastroenterol Hepatol, 23, 785 - 796
Pilot feasibility study to determine the utility of direct access and quantitative magnetic resonance cholangiopancreatography (MRCP) in the assessment of suspected acute biliary or ductal gallstone presentations.
Journal article
Novak A. et al, (2025), BMC Gastroenterol, 25
Precision in Liver Diagnosis: Varied Accuracy Across Subgroups and the Need for Variable Thresholds in Diagnosis of MASLD.
Journal article
Vali Y. et al, (2025), Liver Int, 45
Association between non-invasive biomarkers and quality of life in Primary Sclerosing Cholangitis.
Journal article
Dai J. et al, (2025), PLoS One, 20
Long term health outcomes in people with diabetes 12 months after hospitalisation with COVID-19 in the UK: a prospective cohort study.
Journal article
Gharibzadeh S. et al, (2025), EClinicalMedicine, 79
Validation of quantitative magnetic resonance cholangiopancreatography metrics in the prediction of event-free survival in primary sclerosing cholangitis: an International PSC study group collaboration
Conference paper
Middelburg T. et al, (2025), JOURNAL OF HEPATOLOGY, 82
Quantitative MRI metrics in the liver and pancreas for disease assessment in IgG4-related sclerosing cholangitis with autoimmune pancreatitis
Conference paper
Jackson E. et al, (2025), JOURNAL OF HEPATOLOGY, 82
Comparison of hepatocellular carcinoma risk scores in people with cirrhosis: concordance analysis of four prediction tools
Conference paper
Yarar S. et al, (2025), JOURNAL OF HEPATOLOGY, 82
Comparing ultrasound and magnetic resonance imaging for hepatocellular carcinoma screening in high-risk populations: a systematic review and meta-analysis of prospective cohorts
Conference paper
Passos P. et al, (2025), JOURNAL OF HEPATOLOGY, 82
Optimizing non-invasive screening to reduce biopsy screen failure in clinical trials for metabolic dysfunction-associated steatotic liver disease
Conference paper
Vali Y. et al, (2025), JOURNAL OF HEPATOLOGY, 82